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Obesity, which is becoming one of the major health hazards in developed and developing
societies, results from a long-term positive energy balance. Body-weight regulation and stability
depend on an axis with three interrelated components: food intake, energy expenditure and
adipogenesis, although there are still many unknown features concerning fuel homeostasis and
energy balance. Biochemical processes are interconnected, and a separate consideration of each
component is often useful for methodological purposes and to achieve a better understanding of
the whole system. Thus, many different experimental approaches can be applied by using
laboratory animals, cell culture or human subjects to unravel the molecular mechanisms which
participate in body-weight regulation. Thus, both in vitro (cellular and subcellular models) and in
vivo methods have dramatically increased our knowledge of weight control. Several strategies in
obesity research are reported here, exploiting the opportunities of the molecular era as well as
novel whole-body approaches, which will impact on the development of new targets for obesity
management and prevention.
Obesity genes: Adipose tissue: Energy expenditure: Body composition
UCP, uncoupling proteinLessons from molecular and cellular biology and genetics
Application of the concepts and techniques of molecular
biology has led to major advances over recent years in the
understanding of the mechanisms underlying the regulation
of energy balance and obesity development (Trayhurn,
1998). Particular progress has come from the identification,
by approaches such as positional cloning, of the mutant
genes involved in the initiation of obesity in rodent
models in which the disorder is genetically determined.
The localization of mutant genes in these animals has led to
the identification of ‘novel’ proteins and previously
unrecognized physiological regulatory systems. This
progress is especially evident in the case of the 16 000
relative molecular mass hormone, leptin, a mutation in the
leptin gene causing the obesity of the ob/ob mouse (Zhang
et al. 1994). The mouse db gene and the rat fa gene encode
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the receptor for leptin, and a mutation in these genes is
responsible for the obesity of the db/db mouse and fa/fa rat
respectively (Trayhurn et al. 1999). Other single-gene
mutation rodent models of obesity have allowed other genes
and gene products potentially involved in human obesity,
such as carboxipeptidase E and the agouti signalling protein
to be identified (Perusse et al. 1999).
Homologues of the mouse ‘obesity genes’ have been
reported in human subjects, and searches have been under-
taken for mutations in these genes in obese subjects, and for
specific polymorphisms, which may be linked to increased
body fat or the tendency to fatness (James & Ralph, 1999).
Three reports have now identified mutations in the coding
region of the leptin and leptin receptor genes in association
with severe obesity (Montague et al. 1997; Clement et al.
1998; Strobel et al. 1998). The significance of these findings
is not only the presence of mutations per se, but the
demonstration that the leptin system is physiologically
important in the regulation of body fat and energy balance in
man as well as in rodents.
Mutations and polymorphisms can be identified in genes
which are, or might be, linked with obesity by employing
Southern blotting. Expression of a given gene may be
assessed in tissue samples in vitro by Northern blotting and
by other techniques (RNase protection, restriction enzyme
methodology, reverse transcription–polymerase chain
reaction) for determining specific mRNA (Hesketh & Part-
ridge, 1996; Clarke & Sooja, 1998). These methodologies
are able to indicate those tissue(s) expressing a particular
gene, which is important in gaining understanding of the
physiological function of the encoded protein, but it also
enables changes in gene expression in obesity to be deter-
mined and whether any alterations are primary or secondary.
Furthermore, nutritional, hormonal and neural factors
involved in the regulation of specific genes can be investi-
gated as potential mediators of some obesity genotypes.
Other methods for detection of mutations are denaturing
gradient gel electrophoresis, carbodiimide modification,
single-strand conformational polymorphisms, heteroduplex
analysis, RNAase or chemical cleavage methods, allele-
specific oligonucleotide, ligation detection, artificial intro-
duction of restriction sites and single base primer extension
(Beaudet, 1998). Those studies have been complemented by
quantitative trait loci trials from cross-breeding experiments
as well as by association and linkage studies between
candidate genes with the human obesity phenotype through
different genetically-based methods and epidemiological
studies. The number of genes putatively involved in obesity
is increasing very rapidly and now approaches 200,
including uncoupling proteins (UCP), β2- and β3-adrenergic
receptors, peroxisome proliferator-activated receptor,
adipocyte fatty acid-binding protein, pro-opiomelanocortin,
melanocortin-4 and -5 receptors etc. which may be impli-
cated in food intake, adipogenesis or energy expenditure
control (Perusse et al. 1999; Willett, 1999).
A substantial part of basic knowledge about fat cell
function is derived from in vitro studies on adipose tissue
(Lafontan & Arner, 1996). Isolated fat cells have been
extensively used for their rapid metabolic responses. It is an
ideal system for the study of metabolite transport,
delineation of mechanisms of hormone action and pharma-
cological effects. However, some results may not be
representative of the whole adipose tissue mass.
Preservation of fat cell integrity depends on the success of
the isolation procedure. Recovery of the whole fat cell
population of a given adipose tissue requires attention, since
large fat cells are fragile and small fat cells may be lost
during isolation. Moreover, artifactual leakage of adenosine
from isolated fat cells alters metabolic variables (lipolysis,
glucose transport). Maintenance of isolated human
adipocytes for several days is difficult because of the
fragility of the cells, the alteration of hormonal signal
transduction and the marked decrease in gene expression.
Adipose tissue explants that partly maintain the in vivo
structure of the tissue and permit long-term culture,
although less suitable than isolated fat cells for transport and
pharmacological studies, seem to be more satisfactory for
the in vitro study of some adipocyte functions and the
regulation of gene expression.
The dissipation of energy as heat by adaptive mito-
chondrial thermogenesis may play a role in body-weight
control. The UCP family of mitochondrial inner-membrane
transporter proteins participate in uncoupling respiration
from ATP synthesis (Nicholls & Locke, 1984). The recent
identification of novel UCP (mainly UCP2 which is widely
expressed and UCP3 which is mainly present in muscle) has
attracted new interest, although their role, particularly in
human subjects is not clear (Schrauwen et al. 1999).
Lipid-soluble vitamins, fatty acids, and particularly the
retinoids, appear to be involved in the regulation of UCP1
gene expression, which has been the focus of extensive
effort (Puigserver et al. 1996; Bonet et al. 1997).
Lessons from animal studies
Small animals (mainly rats or mice) are very useful for
carrying out both nutritional and obesity-related studies. The
utilization of metabolism cages for the individual recording
of food and water consumption as well as outputs of urine
and faeces allows the determination of nutrient balance and
the assessment of dietary influences on growth and body
composition (Esteve et al. 1992). Experimental trials can be
performed by using dietary interventions with different
energy content and macronutrient composition, including
the utilization of highly-palatable foods and cafeteria diets
to induce overweight, which provide a model for under-
standing body-weight regulation. In addition, the use of
rodents in metabolism studies greatly expands the method-
ological approaches possible, since experimental animals
can be cannulated under anaesthesia and used for the
determination of arterio–venous differences in key organs
and for tissue blood flow measurement. Circadian rhythms
of individual tissue temperature can be determined by
implantation of temperature probes in different tissues. In
addition, the research on animal models (mouse or rat) with
both lean or obese phenotypes, either due to known muta-
tions (db/db and ob/ob mice and fa/fa rats) or as a result of
direct genetic manipulation (a knockout or transgenic
animal) of key genes related to body-weight control, can
facilitate the study of metabolic or nutritional variables
by the direct comparison between the lean and obese
individuals (Closa et al. 1992; Docherty, 1996).
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In addition, energy expenditure determinations by
respiratory gas exchange (CO2 and O2) in rodents and other
animals are valuable tools to investigate short- and long-
term changes in organ weights (including fat tissue). Body
composition may be measured by different chemical, elec-
tromagnetic, ultrasound and other procedures. Furthermore,
substrate utilization and fate, as well as metabolic pathways,
can be appropriately assessed by using different stable or
radiolabelled tracers in order to measure energy metabolism,
kinetics and nutrient turnover. Finally, the screening of
the role of different neuropeptides or molecules such as
cocaine- and amphetamine-regulated transcript, serotonin,
leptin, orexins and neuropeptide Y involved in appetite
and energy metabolism regulation can be conveniently esti-
mated by using conventional or stereotactic administration,
with suitable methods and pharmacological equipment
(Schwartz et al. 1999). Research on neuroendocrine and
sympathetic signals as well as on the hypothalamic control
of energy balance has benefitted from the use of suitable
animal models (Bray, 1999; Webber & Macdonald, 1999;
Williams et al. 1999).
Searching for genes differentially expressed in
obesity models
RNA fingerprinting, or differential display, is one of the
several molecular biology strategies available to detect
genes differentially expressed between individuals who have
developed diet-induced obesity v. control lean individuals.
The availability of a rat model for diet-induced obesity
allows the comparision of white fat, skeletal muscle and
liver tissue samples in order to identify genes that might
have an important role in the development of obesity. This
approach is considerably more straightforward than other
approaches described previously, such as differential
screening or subtractive hybridization, and has important
advantages; much less sample is needed, it allows the com-
parison of multiple samples and the simultaneous identifi-
cation of genes that are either up or down regulated. The
most important pitfall is the relatively high number of false
positives that can be obtained, which makes careful screen-
ing absolutely necessary before further efforts are focused
toward any particular sequence identified. To simplify the
task of handling the numerous possible positives several
alternatives have been proposed, although Northern blot
confirmation of differential gene expression is required to
obtain a definitive answer (Liang & Pardee, 1998).
RNA fingerprinting, or differential display, has already
been applied successfully in a considerable number of
studies, resulting in the identification of new genes or
demonstrating the role of previously characterized ones in
the process under investigation. These studies include
adipocyte differentiation (Hu et al. 1996), the hypothalamus
and skeletal muscle of genetically-obese (ob/ob) mice
(Vicent et al. 1998), and even rodent models (OM and
S5B/PI strains) of diet-induced obesity (Lin et al. 1998).
An alternative and promising new technology is the
oligonucleotide microarray (DNA chips)-based hybrid-
ization analysis, which potentially allows rapid and cost-
effective screens for all possible mutations and sequence
variations in genomic DNA (Hacia, 1999). Technological
advances within the past decade have made possible the
application of this technology to medical genetics.
Gene transfer strategies in obesity models
Gene delivery technology presents the major obstacle in the
development of vectors which appropriately transfer and
express relevant gene products in specific tissues. Thus, the
ideal gene-transfer vector would be injectable, targetable to
specific sites in vivo, non-immunogenic, able to be regulated
and maintain long-term gene expression.
In an attempt to investigate some processes involved in
obesity, delivery of the leptin cDNA by viral or non-viral
vectors in lean and genetically-obese (ob/ob) animals has
been performed. A single leptin gene injection into the
tibialis anterior muscle of mice resulted in a 2-fold increase
in serum leptin levels, together with a modest and reversible
reduction in food intake and weight gain in ob/ob mice
(Marti et al. 1998). Furthermore, treatment of these animals
with a recombinant adenovirus expressing the mouse leptin
cDNA (AdRSV-leptin) resulted in a rapid reduction in food
consumption and drastic weight loss, which led to a
complete, although transient, correction of obesity and
diabetes as serum leptin levels decreased after 2–3 weeks
(Muzzin et al. 1996). Comparing the efficacy of daily
injection of recombinant leptin protein with adenovirus-
mediated delivery of leptin for obesity treatment, Morsy
et al. (1998b) found that there is a continuous chronic
secretion of leptin mediated by gene delivery v. the inter-
mittent bolus delivery and rapid clearance of the daily leptin
protein injection. Furthermore, in vivo studies suggest that
leptin effects are better achieved at the lower steady-state
levels achieved by gene therapy. However, adenoviral-
mediated in vivo gene transfer and expression are limited in
part by cellular immune responses to viral-encoded proteins
and/or transgene immunogenicity. To diminish these
responses helper-dependent vectors have been developed in
which the viral protein coding sequences are completely
eliminated. These helper-dependent vectors have up to 37 kb
insert capacity, are easily propagated in a CAMP response
element recombinase-based system, and can be produced to
high concentration and purity. In contrast to the liver
toxicity, inflammation and cellular infiltration observed
with first-generation E1-deleted adenovirus vectors, helper-
dependent leptin delivery was connected with a significant
improvement in associated safety and toxicity (Morsy et al.
1998a). The greater safety, insertion capacity and efficient
gene delivery of the helper-dependent vectors represent
favourable features for clinical gene-therapy applications.
Moreover, recombinant adeno-associated virus carrying
the leptin cDNA were also constructed and the effects
characterized after one intramuscular administration in
ob/ob mice. Contrary to results obtained after adenoviral-
based leptin delivery, the weight-reducing effects lasted for
at least 6 months and the leptin expression for at least 3·5
months (Morsy et al. 1998a). Expression of a marker gene
from recombinant adeno-associated virus vectors injected
into muscle gradually increased over a period of 4–6 weeks
before stabilizing, while adenoviral gene delivery resulted in
rapid onset of protein expression which is extinguished
within 2 weeks, presumably by immune responses to
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adenoviral proteins. The recombinant adeno-associated
virus–leptin-treated animals showed normalization of
metabolic abnormalities, including hyperglycaemia, insulin
resistance, impaired glucose tolerance and lethargy which
leads to a long-term correction of obesity and diabetes in the
obese (ob/ob) mouse model. It is thus encouraging that
gene-transfer technology in obesity models (monogenic) is
progressing, although substantial research efforts are needed
to be able to screen and treat (polygenic) obesity.
Lessons from human studies
Methodologies for the study of human body-weight
regulation must be focused on the hypothesis to be tested,
and must have the sensitivity and specificity to yield a
definitive result.
Assessing energy expenditure and lipogenesis by using
stable isotopes
The accuracy and non-invasive nature of stable-isotope-
based methods make them ideal for the study of human
energy metabolism (Diaz & Marques-Lopes, 1999). The
doubly-labelled water method was developed 50 years ago,
but nearly 40 years passed before it became a major tool for
human nutrition research. This method has been applied
extensively to the study of the growing problem of obesity
in order to determine the role of energy expenditure and
physical activity in weight control. Furthermore, it has
provided a new means of validating methods for assessing
dietary intake (Schoeller, 1999).
Energy metabolism is regulated by several neuro-
endocrine and nutritional factors affecting the macronutrient
balance (Tappy et al. 1998). Thus, body lipid, carbohydrate
and protein accumulation and metabolic fate can be assessed
using in vivo and in vitro methods by measuring the rate of
the different metabolic pathways (dynamic aspects), and
also the net balance which may lead to nutrient deposition or
loss (static aspects). The quantification of nutrient synthesis
and breakdown can be performed by using different
radioactive or stable isotopes as tracers within different
precursors. As an example, fatty acid synthesis can be
independently measured by the intravenous infusion of
[13C]acetate and the application of the mass isotopomer
distribution analysis technique (Hellerstein et al. 1996).
This method uses probability analysis to measure the
synthesis of biological polymers. It is based on the
mathematical principle that the labelling pattern of a
polymer synthesized from a stable-isotope-labelled
precursor will conform to a predicted binomial or multi-
nomial expansion. The actual isotope enrichment is
measured by GC–mass spectrometry. This method requires
that newly-synthesized (labelled) and preformed
(unlabelled) components mix in the liver and communicate
with plasma VLDL over the period of the isotope infusion.
It also assumes that the major de novo fatty acid is only a
single fatty acid, with minor elongation and/or desaturation
processes. Finally, the infused isotopically-labelled acetate
should have no physiologically important effect. This
methodology can be applied to assess lipogenesis in very
different nutritional and physiopathological conditions such
as diabetes, obesity etc. (Martinez & Marti, 1998;
Hellerstein, 1999). Of course, other tracers are also valuable
means of quantifying nutrient turnover (oxidation, depo-
sition etc.) by using appropriate markers in order to measure
the oxidative hierarchy of macronutrients, the whole-body
macronutrient balance, glucose–fatty acid interactions and
the steady-state of weight maintenance at which the fuel
mixture matches the amount and composition of dietary
nutrient intake (Jecquier & Tappy, 1999; Schutz, 1999).
Assessing human body composition
In recent years there has been renewed interest in the
individual components of body weight. This interest has
included developments in the methodology for the study of
nutrient partitioning, field methods suitable for large
epidemiological studies and independent techniques for the
measurements of fat distribution, muscle mass or other
elements of body composition. These methods have been
extensively reviewed (for example, see Jebb, 1998).
Detailed studies of body composition are essential in a
number of areas:
(1) to define reference standards for body composition
during growth and development;
(2) to define the relationship between body composition,
including fat distribution, and long-term health outcomes;
(3) to measure differences in body composition between
individuals or in response to different manipulations in
order to further our understanding of the mechanisms
regulating nutrient partitioning;
(4) to test the acute and chronic impact of interventions
on body fat mass in both experimental, laboratory-based and
community studies.
For epidemiological studies the emphasis is on methods
which are capable of ranking individuals accurately and
those which have minimal observer error. Here, new
developments which make current methods simpler, cheaper
or more practical will become increasingly important. For
more detailed metabolism studies the problem lies not so
much in the methods themselves but in the models used to
describe the composition of the body. Classical two-
compartment techniques, which divide the body into fat and
fat-free tissue are gradually being replaced by four-
compartment models comprising water, bone mineral, fat
and protein, or even further sub-compartments (Fuller et al.
1992).
Unfortunately, at the present time even the best methods
or models are not always of sufficient sensitivity or
specificity to yield definitive conclusions in some research
studies. Even the ‘reference’ methods such as densitometry,
total body water or dual-energy X-ray absorptiometry are
unable to measure body fat to much better than ± 1 kg, and
‘field’ methods such as skinfold thicknesses or bioelectrical
impedance may be considerably worse (Jebb et al. 2000).
However, changes in body composition can be estimated
more accurately using classical measurements of energy
balance. Using continuous measurements of substrate
balance within the confines of a whole-body calorimeter,
energy intake and expenditure can be measured precisely, to
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within ± 9 g fat/d and 20 g carbohydrate/d (Jebb et al. 1993).
Accordingly, it is possible to examine the precise impact of
a variety of interventions over very short periods of time and
in much smaller groups of subjects than is necessary when
using other methods (Poppitt et al. 1997).
In spite of their limitations, the careful application of
current methodologies to measure body composition in vivo
and the development of other methods, including an
imaging technique (Sjostrom, 1991), targeted at specific
research questions will be a critical element in the devel-
opment of our understanding of body-weight regulation.
Strategies to investigate human adipose
tissue functions
Adipose tissue is a heterogeneous metabolic organ (Havel,
1999). A number of in vivo and in vitro techniques are
available, with different advantages and limitations, for
investigating various aspects of adipose tissue metabolism.
Tracer methods, using glycerol or fatty acids labelled with
stable or radioactive isotopes, allow the evaluation of
whole-body metabolic rates, but it is necessary to utilize
complex multicompartmental models to derive equations
reflecting physiological events, although they do not give
information about regional adipose tissue metabolism.
Measurements of arterio–venous concentration differences
across subcutaneous adipose tissue, combined with
measurements of adipose tissue blood flow, allow
measurement of uptake and output of metabolites or any
other exogenous substances.
In human subjects a new technique has been developed
recently to quantify substrate turnover in the abdominal
subcutaneous adipose tissue in vivo after cannulation of the
left superficial epigastric vein for sampling adipose tissue
venous blood (Frayn et al. 1993). The method, which is
relatively difficult and time-consuming, is restricted to
human subcutaneous fat deposits. The microdialysis
technique is a promising in vivo method which allows
continuous sampling and manipulation of the interstitial
space of adipose tissue without influencing whole-body
function (Lafontan & Arner, 1996). Microdialysis measures
the concentration of a particular substance in the interstitial
space. The technique gives information on subcutaneous fat
deposits, allowing long-term continuous measurements and
local manipulation of adipose tissue metabolism, which is
essentially suitable for measuring small and water-soluble
molecules which easily cross the dialysis membrane (the
usual cut-off point of membranes is 20 000 Da). It is
possible to estimate the true concentration of a substance in
the extracellular space of adipose tissue with microdialysis
when using a calibration technique to determine the
recovery rate from the dialysis probe (depending on the
length of the dialysis probe and the perfusion speed). It is
also possible to indirectly estimate local blood flow in
adipose tissue by microdialysis (Galitzky et al. 1993).
In vivo regulation of muscle and adipose tissue
gene expression
In spite of body-weight regulation and adaptation to
environmental factors such as nutrition and lifestyle by
changes in gene expression, obesity and other complications
may occur (Lean, 1999). In pathological states, such as
obesity or non-insulin-dependent diabetes mellitus, defects
in this regulation could occur and could explain inter-
subject variations in the response to different diets and
obesity occurrence. However, the study of such regulation
in human subjects has been limited by the lack of access to
different tissues. The development of micro-methods such
as the reverse transcription–competitive polymerase chain
reaction allows the measurement of mRNA concentrations
in very small amounts of tissue that could be safely obtained
(Auboeuf et al. 1997). Thus, specific assays have been
designed in order to quantify mRNA from numerous target
genes involved in insulin signalling (insulin receptor, insulin
receptor substrate 1, phosphatidylinositol-3-kinase), in
glucose metabolism (glucose transporter 4, glycogen
synthase, hexokinase II) and in lipid metabolism (hormone-
sensitive lipase, lipoprotein lipase, leptin and other
regulatory processes (tumour necrosis factor, plasminogen
activator inhibitor-1 etc.).
In this context, the effects of insulin infusion, energy
restriction and lipid infusion were studied in control and
obese subjects, and in subjects with non-insulin-dependent
diabetes who were submitted to muscle (vastus lateralis;
60–80 mg) and periumbilical subcutaneous adipose tissue
biopsies before and after the nutritional intervention in
order to quantify changes in gene expression. Defects
in phosphatidylinositol-3-kinase, hormone-sensitive lipase
and UCP2 gene expression regulation were found, which
may help us to understand the physiopathology of non-
insulin-dependent diabetes (Laville et al. 1996; Andreelli
et al. 1999). Other genes potentially involved in human
thermogenesis (UCP, β3-adrenergic receptor, peroxisome
proliferator-activated receptor-γ coactivator-1) and
adipocyte differentiation (peroxisome proliferator-activated
receptor adipocyte fatty acid-binding protein) have been
recently identified and are under study.
Further assays are now under development, combining
studies in human subjects with in vivo and in vitro systems
(Yanovski & Yanovski, 1999) in order to assess the
mechanisms involved in body-weight regulation and obesity
(Martinez, 1999). This assay development is of a major
importance in terms of clinical nutrition, and for public
health, since the prevalence of obesity is increasing at
alarming rates in many populations (Pi-Xunyer, 1999).
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